HCA Healthcare Price to Sales Ratio 2012-2025 | HCA
Historical PS ratio values for HCA Healthcare (HCA) over the last 10 years. The current P/S ratio for HCA Healthcare as of February 10, 2026 is .
| HCA Healthcare P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-02-10 | 502.05 | 1.59 | |
| 2025-12-31 | 466.86 | $316.06 | 1.48 |
| 2025-09-30 | 425.57 | $301.33 | 1.41 |
| 2025-06-30 | 381.85 | $287.48 | 1.33 |
| 2025-03-31 | 343.75 | $276.81 | 1.24 |
| 2024-12-31 | 297.92 | $268.05 | 1.11 |
| 2024-09-30 | 402.55 | $260.81 | 1.54 |
| 2024-06-30 | 317.68 | $252.40 | 1.26 |
| 2024-03-31 | 329.16 | $243.17 | 1.35 |
| 2023-12-31 | 266.58 | $233.97 | 1.14 |
| 2023-09-30 | 241.70 | $223.96 | 1.08 |
| 2023-06-30 | 297.52 | $216.75 | 1.37 |
| 2023-03-31 | 257.96 | $209.79 | 1.23 |
| 2022-12-31 | 234.18 | $202.92 | 1.15 |
| 2022-09-30 | 178.95 | $196.15 | 0.91 |
| 2022-06-30 | 163.20 | $191.64 | 0.85 |
| 2022-03-31 | 242.61 | $184.99 | 1.31 |
| 2021-12-31 | 248.19 | $177.08 | 1.40 |
| 2021-09-30 | 234.01 | $172.85 | 1.35 |
| 2021-06-30 | 198.94 | $164.48 | 1.21 |
| 2021-03-31 | 180.82 | $153.48 | 1.18 |
| 2020-12-31 | 157.50 | $150.14 | 1.05 |
| 2020-09-30 | 119.14 | $147.38 | 0.81 |
| 2020-06-30 | 92.75 | $145.14 | 0.64 |
| 2020-03-31 | 85.86 | $148.92 | 0.58 |
| 2019-12-31 | 140.77 | $147.27 | 0.96 |
| 2019-09-30 | 114.35 | $142.98 | 0.80 |
| 2019-06-30 | 127.93 | $138.83 | 0.92 |
| 2019-03-31 | 123.00 | $135.13 | 0.91 |
| 2018-12-31 | 117.07 | $131.15 | 0.89 |
| 2018-09-30 | 130.55 | $127.67 | 1.02 |
| 2018-06-30 | 96.02 | $124.21 | 0.77 |
| 2018-03-31 | 90.48 | $120.33 | 0.75 |
| 2017-12-31 | 81.65 | $116.54 | 0.70 |
| 2017-09-30 | 73.98 | $112.35 | 0.66 |
| 2017-06-30 | 81.06 | $109.79 | 0.74 |
| 2017-03-31 | 82.72 | $107.08 | 0.77 |
| 2016-12-31 | 68.81 | $104.12 | 0.66 |
| 2016-09-30 | 70.30 | $101.25 | 0.69 |
| 2016-06-30 | 71.59 | $98.00 | 0.73 |
| 2016-03-31 | 72.55 | $95.17 | 0.76 |
| 2015-12-31 | 62.87 | $92.41 | 0.68 |
| 2015-09-30 | 71.91 | $89.79 | 0.80 |
| 2015-06-30 | 84.33 | $87.29 | 0.97 |
| 2015-03-31 | 69.93 | $84.61 | 0.83 |
| 2014-12-31 | 68.22 | $81.69 | 0.84 |
| 2014-09-30 | 65.55 | $79.43 | 0.83 |
| 2014-06-30 | 52.41 | $77.05 | 0.68 |
| 2014-03-31 | 48.80 | $74.92 | 0.65 |
| 2013-12-31 | 44.35 | $73.87 | 0.60 |
| 2013-09-30 | 39.74 | $73.10 | 0.54 |
| 2013-06-30 | 33.52 | $72.40 | 0.46 |
| 2013-03-31 | 37.77 | $71.84 | 0.53 |
| 2012-12-31 | 28.04 | $71.93 | 0.39 |
| 2012-09-30 | 26.47 | $69.24 | 0.38 |
| 2012-06-30 | 24.23 | $65.45 | 0.37 |
| 2012-03-31 | 19.70 | $61.22 | 0.32 |
| 2011-12-31 | 16.26 | $58.92 | 0.28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $113.378B | $75.600B |
| HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.407B | 17.08 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Medpace Holdings (MEDP) | United States | $16.568B | 41.13 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.545B | 0.00 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.070B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.408B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |